These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6046257)

  • 41. Neurofibrillary tangles induced by vincristine and vinblastine sulfate in central and peripheral neurons in vitro.
    Seil FJ
    Exp Neurol; 1968 Jun; 21(2):219-30. PubMed ID: 5675328
    [No Abstract]   [Full Text] [Related]  

  • 42. Aluminum: a role in degenerative brain disease associated with neurofibrillary degeneration.
    McLachlan DR; Van Berkum MF
    Prog Brain Res; 1986; 70():399-410. PubMed ID: 3554357
    [No Abstract]   [Full Text] [Related]  

  • 43. Aluminum and neurodegenerative disease: therapeutic implications.
    McLachlan DR; Kruck TP; VanBerkum MF
    Am J Kidney Dis; 1985 Nov; 6(5):322-9. PubMed ID: 2865894
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative immunocytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies.
    Ghetti B; Gambetti P
    Brain Res; 1983 Oct; 276(2):388-93. PubMed ID: 6354362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synaptic density in chronic animals with experimental neurofibrillary changes.
    Uemura E; Ireland WP
    Exp Neurol; 1984 Jul; 85(1):1-9. PubMed ID: 6539712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental neurofibrillary degeneration and altered electrical activity.
    Crapper DR
    Electroencephalogr Clin Neurophysiol; 1973 Dec; 35(6):575-88. PubMed ID: 4128153
    [No Abstract]   [Full Text] [Related]  

  • 47. Quantitative studies on aluminum deposition and its effects on neurofilament protein expression and phosphorylation, following the intraventricular administration of aluminum maltolate to adult rabbits.
    Savory J; Herman MM; Hundley JC; Seward RL; Griggs CM; Katsetos CD; Wills MR
    Neurotoxicology; 1993; 14(1):9-12. PubMed ID: 8361684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration.
    Crapper DR; Dalton AJ
    Physiol Behav; 1973 May; 10(5):925-33. PubMed ID: 4577243
    [No Abstract]   [Full Text] [Related]  

  • 49. Experimental aluminium encephalopathy: quantitative EEG analysis of aluminium bioavailability.
    Cutrufo C; Caroli S; Delle Femmine P; Ortolani E; Palazzesi S; Violante N; Zapponi GA; Loizzo A
    J Neurol Neurosurg Psychiatry; 1984 Feb; 47(2):204-6. PubMed ID: 6707660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunochemical cross-reactivity of normal neurofibrils and aluminum-induced neurofibrillary tangles. Immunofluorescence study with antineurofilament serum.
    Dahl D; Bignami A
    Exp Neurol; 1978 Jan; 58(1):74-80. PubMed ID: 338332
    [No Abstract]   [Full Text] [Related]  

  • 51. Aluminum metabolism and toxicity in uremia.
    Alfrey AC
    J UOEH; 1987 Mar; 9 Suppl():123-32. PubMed ID: 3602743
    [No Abstract]   [Full Text] [Related]  

  • 52. [Presence of high concentrations of aluminum in neurons of a patient dying from a rapidly developing dementia].
    Galle P; Meyrignac C; Heine P
    C R Acad Sci III; 1984; 299(13):535-9. PubMed ID: 6437618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Aluminum and the encephalopathy of hemodialysis patients].
    Cartier F; Guenel J; Chatel M
    Nephrologie; 1981; 2(3):89-91. PubMed ID: 7301033
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chronic toxic effects of aluminum on nervous system in rabbits].
    Zhang WQ; Xu GS; Huang GW
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 May; 28(3):158-61. PubMed ID: 7842872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphometric studies of myelination in the spinal cord of mice exposed developmentally to aluminum.
    Golub MS; Tarara RP
    Neurotoxicology; 1999 Dec; 20(6):953-9. PubMed ID: 10693976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Aluminum gels in chronic kidney failrue patients. A potential risk of encephalopathy and osteopathy].
    Rottembourg J; Jaudon MC; Legrain M; Galli A
    Ann Med Interne (Paris); 1980; 131(2):71-4. PubMed ID: 7396323
    [No Abstract]   [Full Text] [Related]  

  • 57. Progressive leukoencephalopathy associated with aluminum deposits in myelin sheath.
    Itoh M; Suzuki Y; Sugai K; Kozuka N; Ohsawa M; Otsuki T; Goto Y
    J Child Neurol; 2008 Aug; 23(8):938-43. PubMed ID: 18660477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aluminum neurotoxicity and Alzheimer's disease.
    Still CN
    J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860
    [No Abstract]   [Full Text] [Related]  

  • 59. Aluminum toxicity in mammals: a minireview.
    Cannata JB; Domingo JL
    Vet Hum Toxicol; 1989 Dec; 31(6):577-83. PubMed ID: 2694586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histochemical localization of aluminum in the rabbit CNS.
    Wen GY; Wisniewski HM
    Acta Neuropathol; 1985; 68(3):175-84. PubMed ID: 2417440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.